AI English summary of an SEC filing — figures as filed
GE HealthCare GEHCGE HealthCare said total revenues for 2023 were $19,552 million, up 7% ($1,211 million) as reported and 8% on an organic basis. The company said sales of products rose 9% ($1,083 million), with growth across all segments.
Key points
AI summaryGE HealthCare said total revenues for 2023 were $19,552 million, up 7% ($1,211 million) as reported and 8% on an organic basis. The company said sales of products rose 9% ($1,083 million), with growth across all segments.
The company said operating income for 2023 was $2,435 million, down $87 million. It said Adjusted EBIT rose $95 million to $2,956 million, with an Adjusted EBIT margin of 15.1%, while the margin fell 50 basis points.
The company said net income attributable to GE HealthCare for 2023 was $1,568 million, down $348 million. It cited interest on the debt securities it issued in November 2022 and on the Term Loan Facility it drew in January 2023 as the reasons interest and other financial charges – net rose $465 million.
The company said cash from operating activities for 2023 was $2,101 million. After additions to PP&E of $387 million, free cash flow was $1,715 million. As of December 31, 2023, cash, cash equivalents, and restricted cash totaled $2,504 million.
Key figures
Fiscal year ended December 31, 2023
- Revenue
- $19.6B
- Operating income
- $2.4B
- Net income
- $1.6B
- EPS
- $3.03
- Gross profit
- $7.9B
- Operating cash flow
- $2.1B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
2023 revenue $19,552 million
GE HealthCare said total revenues for 2023 were $19,552 million, up 7% ($1,211 million) as reported and 8% on an organic basis. The company said sales of products rose 9% ($1,083 million), with growth across all segments.
Source · Based on the MD&A text of the filing
Operating income and Adjusted EBIT changes
The company said operating income for 2023 was $2,435 million, down $87 million. It said Adjusted EBIT rose $95 million to $2,956 million, with an Adjusted EBIT margin of 15.1%, while the margin fell 50 basis points.
Source · Based on the MD&A text of the filing
Higher net interest and rising net income
The company said net income attributable to GE HealthCare for 2023 was $1,568 million, down $348 million. It cited interest on the debt securities it issued in November 2022 and on the Term Loan Facility it drew in January 2023 as the reasons interest and other financial charges – net rose $465 million.
Source · Based on the MD&A text of the filing
Operating cash flow and free cash flow
The company said cash from operating activities for 2023 was $2,101 million. After additions to PP&E of $387 million, free cash flow was $1,715 million. As of December 31, 2023, cash, cash equivalents, and restricted cash totaled $2,504 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…